Hybrid therapy as first-line regimen for <i>Helicobacter pylori</i> eradication in a high clarithromycin resistance area: a prospective open-label trial.

Ann Gastroenterol · 2018 · PMC5825950 · PMID 29507467

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

of borderline significanceP=0.05actually significant

However, in both studies the differences were of borderline significance (P=0.05 and P=0.051, respectively).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.